Articles by tag: longevity-biotech

Epigenome editing of aging: results of SynBioBeta 2026

At SynBioBeta 2026, cell stability engineering was presented: AI mapping of aging and proteostasis editing for treating age-related diseases. Learn the details of the breakthrough.

Senolytic dasatinib+quercetin rejuvenated tissues by 2-3 years

Senolytic drugs D+Q reduced biological age in humans for the first time. Learn how removing old cells rejuvenates the body. Read details of the breakthrough.